Share This

Related Topics News - Drugs

     
 < Previous page   Title only   |   Print    Next page > 
     
石藥集團附屬石藥創新首季利潤7,906萬人民幣 倒退38.9%

2024-04-23T  
上海醫藥旗下新開發藥物獲國家藥監局受理

2024-04-22T  
歐盟傳最早4月對中國醫療器械採購啟動調查 或影響中資投標

2024-04-15T  
山東新華製藥股份頭孢克洛膠囊通過仿製藥品質和療效一致性評價

2024-04-10T  
國家醫保局:第九批藥品集採每年為患者節省182億元人幣

2024-04-09T  
山東新華製藥帕拉米韋注射液藥品補充申請獲批

2024-04-08T  
《大行報告》星展削威高股份目標價至6.4元 減肥藥趨勢推動藥品包裝需求

2024-04-08T  
《大行報告》高盛降威高股份目標價8.7元 派息比率提升

2024-04-02T  
《公司業績》山東新華製藥股份全年純利4.97億元人民幣升20.8% 派末期息25分人民幣

2024-03-28T  
《大行報告》大摩降威高股份目標價至6.6元 評級「與大市同步」

2024-03-28T  
 < Previous page    Next page > 

Mobile | Full
Forum rule | About Us | Contact Info | Terms & Conditions | Privacy Statment | Disclaimer | Site Map
Copyright (C) 2024 Suntek Computer Systems Limited. All rights reserved
Disclaimer : In the preparation of this website, 88iv endeavours to offer the most current, correct and clearly expressed information to the public. Nevertheless, inadvertent errors in information and in software may occur. In particular but without limiting anything here, 88iv disclaims any responsibility and accepts no liability (whether in tort, contract or otherwise) for any direct or indirect loss or damage arising from any inaccuracies, omissions or typographical errors that may be contained in this website. 88iv also does not warrant the accuracy, completeness, timeliness or fitness for purpose of the information contained in this website.